| Views | |
|---|---|
| Biomarker and Histopathology Evaluation of Patients with Recurrent Glioblastoma Treated with Galunisertib, Lomustine, or the Combination of Galunisertib and Lomustine | 213 |
| August 2024 | September 2024 | October 2024 | November 2024 | December 2024 | January 2025 | February 2025 | |
|---|---|---|---|---|---|---|---|
| Biomarker and Histopathology Evaluation of Patients with Recurrent Glioblastoma Treated with Galunisertib, Lomustine, or the Combination of Galunisertib and Lomustine | 5 | 5 | 3 | 3 | 2 | 3 | 0 |
| Views | |
|---|---|
| ijms-18-00995.pdf | 200 |
